Environmental debris in the ventilators could manipulate the air pressure, volume or flow and result in hypoventilation or a buildup of carbon dioxide and other gas pressure, according to the FDA.
Philips has received 542 reports about the issue, and no injuries or deaths have been reported as of Aug. 14.
The affected products are some lots of the Trilogy Evo, Evo O2, EV300, and Evo Universal ventilators, which were distributed between March 2019 and March 2023.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
